个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Efficacy and safety of aumolertinib combined with or without chemotherapy as an adjuvant treatment for stage II-IIIA non-small cell lung cancer following complete tumour resection: The first third-generation EGFR-TKI versus chemotherapy phase III clinical study (APEX)

| 导出 |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：
Tan, Feng[1] * ; Wang, Zhijie[2] ; Feng, Gang[3] ; Sun, Daqiang[4] ; Ma, Haitao[5] ; Jiang, Tao[6] ; Wang, Sihua[7] ; Liu, Hongxu[8] ; Hu, Weidong[9] ; Liu, Wei[10] ; Zhu, Yuming[11] ; Li, Hecheng[12] ; Peng, Hao[13] ; Wu, Qingchen[14] ; Shen, Weiyu[15] ; Xu, Shun[16] ; Zhang, Quanren[17] ; Han, Yongtao[18] ; Wang, Jie[2] ; Gao, Shugeng[1] ;
机构： [1]Chinese Acad Med Sci & Peking Union Med Coll, Dept Thorac Surg, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China [2]Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, State Key Lab Mol Oncol,Natl Clin Res Ctr,Canc Ca, Beijing, Peoples R China [3]Sichuan Prov Peoples Hosp, Dept Thorac Surg, Chengdu, Peoples R China [4]Tianjin Chest Hosp, Dept Thorac Surg, Tianjin, Peoples R China [5]Suzhou Univ, Dept Cardiothorac Surg, Affiliated Hosp 1, Suzhou, Peoples R China [6]Air Force Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian, Peoples R China [7]Wuhan Union Hosp, Dept Thorac Surg, Wuhan, Peoples R China [8]Liaoning Canc Hosp & Inst, Dept Thorac Surg, Shenyang, Peoples R China [9]Wuhan Univ, Dept Thorac Surg, Zhongnan Hosp, Wuhan, Peoples R China [10]Jilin Univ, Dept Thorac Surg, Affiliated Hosp 1, Changchun, Peoples R China [11]Shanghai Pulm Hosp, Dept Thorac Surg, Shanghai, Peoples R China [12]Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Thorac Surg, Shanghai, Peoples R China [13]First Peoples Hosp Yunnan Prov, Dept Thorac Surg, Kunming, Peoples R China [14]Chongqing Med Univ, Dept Cardiothorac Surg, Affiliated Hosp 1, Chongqing, Peoples R China [15]Lihuili East Hosp, Dept Cardiothorac Surg, Ningbo Med Ctr, Ningbo, Peoples R China [16]China Med Univ, Dept Thorac Surg, Affiliated Hosp 1, Shenyang, Peoples R China [17]Anhui Med Univ, Dept Thorac Surg, Affiliated Hosp 1, Hefei, Peoples R China [18]Univ Elect Sci & Technol China, Sch Med, Sichuan Canc Hosp & Inst, Dept Thorac Surg,Sichuan Canc Ctr, Chengdu, Peoples R China
出处：
ISSN：
基金：
Hansoh Pharmaceutical Group Company Limited
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2024]版：
无
最新[2023]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
JCR分区：
出版当年[2023]版：
Q1 ONCOLOGY
最新[2023]版：
Q1 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者：
第一作者机构： [1]Chinese Acad Med Sci & Peking Union Med Coll, Dept Thorac Surg, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Tan Feng,Wang Zhijie,Feng Gang,et al.Efficacy and safety of aumolertinib combined with or without chemotherapy as an adjuvant treatment for stage II-IIIA non-small cell lung cancer following complete tumour resection: The first third-generation EGFR-TKI versus chemotherapy phase III clinical study (APEX)[J].JOURNAL OF CLINICAL ONCOLOGY.2024,42(16):
APA：
Tan, Feng,Wang, Zhijie,Feng, Gang,Sun, Daqiang,Ma, Haitao...&Gao, Shugeng.(2024).Efficacy and safety of aumolertinib combined with or without chemotherapy as an adjuvant treatment for stage II-IIIA non-small cell lung cancer following complete tumour resection: The first third-generation EGFR-TKI versus chemotherapy phase III clinical study (APEX).JOURNAL OF CLINICAL ONCOLOGY,42,(16)
MLA：
Tan, Feng,et al."Efficacy and safety of aumolertinib combined with or without chemotherapy as an adjuvant treatment for stage II-IIIA non-small cell lung cancer following complete tumour resection: The first third-generation EGFR-TKI versus chemotherapy phase III clinical study (APEX)".JOURNAL OF CLINICAL ONCOLOGY 42..16(2024)

资源点击量：82587 今日访问量：0 总访问量：681 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持：重庆聚合科技有限公司 地址：云南省昆明市西山区金碧路157号